Mast Therapeutics, Inc. (MSTX)

[gambinilive]

With the potential of their 2 big drugs and both nearing final stages before approval, there is no reason their pps should be below .50. There are many trading at or above anx that are no where close to where anx is in terms of bringing drugs to the market. The shorts have done a good job keeping this down and the bashers have many investors scared, and in turn they sell and cause more to panick sell, thus a snowball effect. This is my opinion, but I do know we have great potential not only in their pipeline, but also possibilities of being bought by a biggie who needs to freshen up their own business. PFE or GSK would be my first guesses.